Navigation Links
FDA Launches Initiative to Develop Innovative External Defibrillators
Date:11/15/2010

SILVER SPRING, Md., Nov. 15, 2010 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced a program aimed at facilitating the development of safer, more effective external defibrillators used to treat abnormal heart rhythms through improved design and manufacturing practices.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

External defibrillators are medical devices designed to diagnose life-threatening abnormal heart rhythms and treat them by delivering electrical energy to the heart to restore its normal rhythm. When used in the first few minutes following a cardiac arrest, they can save lives.

External defibrillators are used successfully thousands of times each year to treat sudden cardiac arrest. Automated external defibrillators (AEDs) are found in public settings and increasingly in homes, airports and office buildings. More complex external defibrillators are used in hospitals by trained health care professionals.

Nearly 300,000 Americans collapse each year when the heart stops pumping blood to the body (sudden cardiac arrest). Those who experience the condition may die if normal rhythms are not restored quickly. Survival depends on a rapid sequence of rescue events that can include the successful delivery of a high-energy shock from an external defibrillator.

During the past five years, the FDA's Center for Devices and Radiological Health (CDRH) has received more than 28,000 medical device reports associated with the failures of external defibrillators and manufacturers conducted dozens of recalls involving hundreds of thousands of the devices.

Many of the types of problems that CDRH has identified are preventable, correctable, and can impact patient safety. These problems include engineering design and manufacturing practices related to the adequate control of components bought from other suppliers.

"These devices play an important role in health care," said CDRH Director Jeffrey Shuren, M.D. "The purpose of our initiative is to improve these technologies so we can save more lives."

As a part of a broad initiative, CDRH is taking steps to work with manufacturers, users and experts in the field to improve the engineering design and manufacturing practices of these devices, and facilitate the development of their next generation.

CDRH intends to release a white paper that describes the actions the Center is taking to improve the safety of external defibrillators used today and to foster the development of safer, more effective technologies in the near future as part of its External Defibrillator Improvement Initiative.

Goals of the initiative include:

  • Promoting the innovation of next-generation external defibrillators to improve safety and effectiveness
  • Enhancing the ability of industry and the FDA to identify and resolve problems with devices currently on the market to address safety risks more quickly and effectively
  • Designating an appropriate premarket regulatory pathway for AEDs that promotes best practices for design and testing.

The initiative kicks off with a public meeting on Dec. 15-16, 2010, at the FDA headquarters in Silver Spring, Maryland where industry and other external stakeholders will discuss ways to improve these devices. The FDA is also collaborating with the University of Colorado's Department of Emergency Medicine to define the enhancements that will improve ease of use and outcomes, such as conducting a multi-city pilot of connecting AEDs with local emergency medical services so that when an AED is used an emergency rescue team is rapidly dispatched.

For more information:

External Defibrillator Improvement Initiative

Visit the FDA on Facebook

RSS Feed for FDA News Releases [what is RSS?]

Media Inquiries: Dick Thompson, 301-796-7566, Dick.Thompson@fda.hhs.gov  

Consumer Inquiries: 888-INFO-FDA

#


'/>"/>
SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PharmaNet Launches New Brand Identity at Upcoming Industry Conferences
2. Laureate Pharma Launches New Regulatory Affairs Services and Appoints Robert G. Burford, Ph.D., as Vice President
3. World-Renowned Singer Youssou NDour Launches NightWatch Program
4. CRi Launches the TRIO™ Multispectral Imaging System for Multi-Analyte Investigation in Tissue
5. IntegenX Launches the Apollo 324 System for Automated DNA Library Preparation at the ASHG Meeting
6. SAFE IN COMMON Launches Global Injection Safety Website
7. Sandata Technologies Launches Enhanced Location Monitoring
8. Talecris Biotherapeutics Launches PROLASTIN®-C in Canada
9. D3 Launches New Suite of Solutions, including the First Radiation Oncology Clinical Pathways Program, at the ASTRO Annual Meeting, October 31 - November 3, 2010 in San Diego
10. Paragon Bioservices Launches Second Expansion to Celebrate its 20th Anniversary
11. Medco Launches Online Safety Net to Increase Adherence and Prevent Avoidable Medication Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... JOSE, Calif. , Feb. 11, 2016 /PRNewswire/ ... pioneered the use of the iFuse Implant System, ... fusion for certain disorders of the sacroiliac (SI) ... showing the cost benefits of MIS SI joint ... dysfunction due to degenerative sacroiliitis or SI joint ...
(Date:2/11/2016)... 11, 2016  AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX ... made at the 38th annual John A. Boswick ... which is being held February 14-18, 2016 in ... latest advancements in wound healing, burn care, and infection ... Australian-New Zealand Burns Association, Academy of Physicians in Wound ...
(Date:2/11/2016)... , Feb. 11, 2016  NanoViricides, Inc. (NYSE ... has entered into an agreement with the University ... drug candidates in standard animal models of ocular ... Research Director. Dr. Romanowski has extensive experience in ... --> Eric Romanowski , Research Director. ...
Breaking Medicine Technology:
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... Florida Hospital ... Lightning take on the St. Louis Blues at the Amalie Arena. The puck drops ... inflatable, walk-through heart exhibit, the MEGA Heart, prior to the game. The MEGA Heart ...
(Date:2/11/2016)... ... , ... The president released a FY 2017 budget request on Tuesday that ... the cost burden to military beneficiaries. , MOAA’s president, retired Air Force Lt. ... including limited quantifiable benefit fixes mixed with numerous beneficiary fee hikes. , “We were ...
(Date:2/11/2016)... Petersburg, FL (PRWEB) , ... February 11, 2016 ... ... providers and advocates will discuss how to improve care by making data on ... pediatric heart disease. The Summit on Transparency and Public Reporting of Pediatric and ...
(Date:2/11/2016)... ... February 11, 2016 , ... Atlantic Information Services, ... Benefit Model: A Case Study for Plans and Purchasers.” Executives from Intel Corp. ... with Intel on value-based health benefits program Connected Care, will discuss the challenges ...
(Date:2/11/2016)... ... 11, 2016 , ... "What holds you back from ... a question as a challenge for his readers to examine the full scale ... (published by Partridge Singapore), Clarke explores the subject with more depth, revealing time-honored ...
Breaking Medicine News(10 mins):